AUDENTES THERAPEUTICS INC's ticker is BOLD and the CUSIP is 05070R104. A total of 149 filers reported holding AUDENTES THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is 0.35 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $20,162,000 | +289.8% | 336,931 | +82.9% | 0.01% | +400.0% |
| Q3 2019 | $5,173,000 | -16.9% | 184,173 | +12.0% | 0.00% | -50.0% |
| Q2 2019 | $6,225,000 | +1780.7% | 164,429 | +1838.1% | 0.00% | – |
| Q1 2019 | $331,000 | -96.6% | 8,484 | -98.2% | 0.00% | -100.0% |
| Q4 2018 | $9,876,000 | +93.7% | 463,228 | +259.6% | 0.00% | +200.0% |
| Q3 2018 | $5,099,000 | -36.3% | 128,805 | -38.5% | 0.00% | -50.0% |
| Q2 2018 | $8,000,000 | +5.0% | 209,378 | -17.5% | 0.00% | 0.0% |
| Q1 2018 | $7,622,000 | +280.1% | 253,659 | +295.2% | 0.00% | +100.0% |
| Q4 2017 | $2,005,000 | -52.5% | 64,179 | -57.4% | 0.00% | 0.0% |
| Q3 2017 | $4,219,000 | +1137.2% | 150,650 | +745.4% | 0.00% | – |
| Q2 2017 | $341,000 | +9.3% | 17,820 | -2.3% | 0.00% | – |
| Q1 2017 | $312,000 | -48.9% | 18,248 | -45.4% | 0.00% | – |
| Q4 2016 | $610,000 | – | 33,434 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SYQUANT CAPITAL SAS | 767,502 | $45,927,000 | 23.65% |
| Chicago Capital Management, LLC | 250,401 | $14,984,000 | 12.57% |
| Foresite Capital Management III, LLC | 233,067 | $13,947,000 | 7.82% |
| Partner Investment Management, L.P. | 17,795 | $1,065,000 | 7.65% |
| RAMIUS ADVISORS LLC | 220,784 | $13,212,000 | 5.68% |
| Beryl Capital Management LLC | 550,426 | $32,937,000 | 5.31% |
| GARDNER LEWIS ASSET MANAGEMENT L P | 647,460 | $38,744,000 | 5.28% |
| FNY Investment Advisers, LLC | 278,861 | $16,687,000 | 5.17% |
| WHITE SQUARE CAPITAL LLP | 112,500 | $6,732,000 | 4.87% |
| Casdin Capital, LLC | 860,000 | $51,462,000 | 4.73% |